Aerospace and Defense

According to a new market report published by Lucintel, the future of the human microbiome market looks promising with opportunities in the medical therapeutic and diagnostic industries. The global human microbiome market is expected to reach an estimated $1.5 billion by 2027 with a CAGR of 17% from 2022 to 2027. The major drivers for this market are increasing focus on human microbiome therapies and technological advancements in metagenomics and next-generation sequencing.

In this market, prebiotics, probiotics, food, medical foods, and drugs are various products of human microbiome used in treatment of various diseases. On the basis of comprehensive research, Lucintel forecasts that the probiotics will remain the largest segment over the forecast period due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.

Within the global human microbiome market, infectious disease will remain the largest disease type over the forecast period due to increasing cognizance of the negative effects of antibiotic use on the natural flora (such as disruptions), which has highlighted the need for specific bacterial-targeted therapies for infectious diseases.

North America will remain the largest region over the forecast period due to increasing incidence of lifestyle-related diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products. APAC is expected to witness the highest growth over the forecast period due rising chronic diseases caused by changes in lifestyle and growing interest in human microbiome treatment approaches.

Emerging trends, which have a direct impact on the dynamics of the industry, include usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity. Enterome, Seres Therapeutics, 4D Pharma, DuPont, Vedanta Biosciences, Osel, Yakult Hoshna, Merck & Co., Second Genome, and Metabiomics Corporation are among the major players of human microbiome.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global human microbiome market by product, disease type, research technology, application, and region, and has compiled a comprehensive research report titled “Growth Opportunities in the Global Human Microbiome Market 2022-2027: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy by providing comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global human microbiome market by product, disease type, research technology, application, and region, as follows:





































This 209-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/human-microbiome-market.aspx or write us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.

This report addresses the following key questions:

Q.1 What are some of the most promising growth opportunities for the global human microbiome market by product (prebiotics, probiotics, food, medical food, and drugs), disease type (infectious, metabolic/endocrine, cancer, blood, and neurological), research technology (proteomics, metabolomics, and genomics), application (therapeutics and diagnostics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 Which region will grow at a faster pace and why?

Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges, and business risks in this market?

Q.5 What are the business risks and competitive threats in this market?

Q.6 What are the emerging trends in this market and the reasons behind them?

Q.7 What are some of the changing demands of customers in the market?

Q.8 What are the new developments in the market and which companies are leading these developments?

Q.9 Who are the major players in this market? What strategic initiatives are being taken by key players for business growth?

Q.10 What are some of the competing products in this market and how big of a threat do they pose for loss of market share by product substitution?

Q.11 What M & A activity has occurred in the last 5 years?